Multiple endocrine neoplasia type 2 laboratory findings

Multiple endocrine neoplasia type 2 Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple endocrine neoplasia type 2 from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Criteria
History & Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Multiple endocrine neoplasia type 2 laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Multiple endocrine neoplasia type 2 laboratory findings
CDC on Multiple endocrine neoplasia type 2 laboratory findings
Multiple endocrine neoplasia type 2 laboratory findings in the news
Blogs on Multiple endocrine neoplasia type 2 laboratory findings
Directions to Hospitals Treating Multiple endocrine neoplasia type 2
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Laboratory Tests

Blood Test

• Elevated Calcitonin (>=100 pg/mL)
• Pentagastrin
• Elevated epinephrine
• Elevated norepinephrine
• Elevated metanephrine
• Elevated vanillylmandelic acid
• Elevated calcium
• Elevated Parathyroid hormone
• Decreased serum phosphate

Urine Test

• Elevated norepinephrine
• Elevated metanephrine
• Elevated vanillylmandelic acid